phorbol 12,13-dibutyrate has been researched along with 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Marala, RB; Mustafa, SJ | 1 |
1 other study(ies) available for phorbol 12,13-dibutyrate and 2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine
Article | Year |
---|---|
Adenosine analogues prevent phorbol ester-induced PKC depletion in porcine coronary artery via A1 receptor.
Topics: Adenine; Adenosine; Animals; Coronary Vessels; Dose-Response Relationship, Drug; Endothelins; Female; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norbornanes; Phenethylamines; Phorbol 12,13-Dibutyrate; Protein Kinase C; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Receptors, Purinergic P2; Swine | 1995 |